⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Dioscin
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-01 — Diosgenin Alleviates Age-Related Sarcopenia by Promoting Satellite Cell Proliferation and Myogenic Differentiation via Activation of the SIRT1/PGC-1α Signaling Pathway.: cross-connection with diosgenin: Diosgenin is the aglycone of dioscin, linking two Dioscorea-derived saponin pages that share overlapping mitochondrial/SIRT1 mechanistic claims. (novelty: 3)
- 2026-08-10 — Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.: C. elegans lifespan/healthspan extension plus 6-month aged-mouse study showing reduced hepatic and skeletal-muscle p16/p21 senescence markers, with mechanistic activation of ER-UPR via XBP-1 and the PERK/IRE1α/ATF6 branches; no human data. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.
10-aug-2026
novelty 3
per-area 3
strengthens